Cellular metabolic and survival signaling pathways

Cellular metabolic and survival signaling pathways encompass a broad array of intracellular networks, such as the PI3K/AKT/mTOR and Raf/MEK/ERK cascades, that integrate external stimuli to govern cell growth, proliferation, and energy use (Source: Nature Reviews Molecular Cell Biology). These pathways are critical for maintaining cellular homeostasis by balancing anabolic and catabolic processes in response to nutrient availability and hormonal signals (Source: Cell Metabolism). Dysregulation of these pathways is a primary driver in oncogenesis, where mutations often lead to constitutive survival signaling and metabolic reprogramming to support rapid tumor growth (Source: Journal of Clinical Investigation). Additionally, defects in metabolic signaling are central to the pathogenesis of insulin resistance and type 2 diabetes (Source: NIH). Pharmacological intervention typically targets specific nodes within these pathways, such as mTOR with sirolimus or AMPK with metformin, to treat malignancy or metabolic dysfunction (Source: PubChem). However, the high degree of crosstalk and feedback loops within these networks often presents challenges, including drug resistance and systemic toxicity (Source: Science Signaling). Therapeutic strategies are increasingly focusing on combination therapies to overcome the compensatory mechanisms that cells employ when a single node is inhibited (Source: Cancer Discovery). Understanding the spatial and temporal dynamics of these signaling networks remains a key area of research for developing more precise and effective treatments (Source: Nature).

Other names

Cellular signaling networksMetabolic and survival pathwaysIntracellular signaling cascadesSurvival signaling pathways

Modulation of intracellular signaling nodes, such as kinases and phosphatases within the PI3K/AKT/mTOR and MAPK/ERK cascades, to regulate cellular energy balance, growth, and programmed cell death.